Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000567936

Apexbio Technology LLC GLYCOHYODEOXYCHOLIC ACID-10mg
SDP

Catalog No. 5000567936
Encompass

Glycohyodeoxycholic acid (CAS No 13042-33-6) is a bile acid derivative prominent in biomedical research particularly in the study of liver diseases and metabolic disorders Originating from the primary bile acids it plays a crucial role in modulating nuclear receptor pathways such as FXR and TGR5 which are pivotal in regulating bile acid homeostasis and glucose metabolism Its in vitro activity is generally observed in the nanomolar to low micromolar range indicating significant potency Typical applications include usage in various cell models for studying cholesterol metabolism and evaluating hepatoprotective properties as well as in animal studies assessing therapeutic efficacy in liver and metabolic disease models This compound is also explored in drug screening processes aimed at developing treatments for cholestatic liver diseases Experimental concentrations typically depend on the specific research design ensuring tailored and precise analytical results

Catalog No. 50-005-67936 Supplier Apexbio Technology LLC Supplier No. C863810
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Glycohyodeoxycholic acid (CAS No 13042-33-6) is a bile acid derivative prominent in biomedical research particularly in the study of liver diseases and metabolic disorders Originating from the primary bile acids it plays a crucial role in modulating nuclear receptor pathways such as FXR and TGR5 which are pivotal in regulating bile acid homeostasis and glucose metabolism Its in vitro activity is generally observed in the nanomolar to low micromolar range indicating significant potency Typical applications include usage in various cell models for studying cholesterol metabolism and evaluating hepatoprotective properties as well as in animal studies assessing therapeutic efficacy in liver and metabolic disease models This compound is also explored in drug screening processes aimed at developing treatments for cholestatic liver diseases Experimental concentrations typically depend on the specific research design ensuring tailored and precise analytical results

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.